• METHYLERGONOVINE CHEMBL1201356 FDA Approved

    Alternate Names:

    Methylergometrine
    Methylergonovine
    LYSERGIC ACID BUTANOLAMIDE
    NCGC00017258-05
    KBIO1_000357
    ERGOLINE-8-CARBOXAMIDE, 9,10-DIDEHYDRO-N-(1-(HYDROXYMETHYL)PROPYL)-6-METHYL-, (8BETA(S))-
    KBIO2_005879
    METHYLERGOBASIN
    LS-64363
    29589-73-9
    ERGOTYL (TN)
    113-42-8
    METILERGOMETRINA [DCIT]
    HSDB 3364
    METHYLERGOMETRINE [INN:BAN]
    AB00514664
    BSPBIO_002023
    151359
    ERGOMETRINE, METHYL-
    RYEGONOVIN
    METHYLERGOMETRINE MALEATE
    LOPAC0_000794
    BSPBIO_000527
    ERGOLINE-8-BETA-CARBOXAMIDE, 9,10-DIDEHYDRO-N-((S)-1-(HYDROXYMETHYL)PROPYL)-6-METHYL-
    METILERGOMETRINIO [INN-SPANISH]
    PRESTWICK3_000374
    9,10-DIDEHYDRO-N-(ALPHA-(HYDROXYMETHYL)PROPYL)-6-METHYL-ERGOLINE-8-BETA-CARBOXAMIDE
    UNII-W53L6FE61V
    SPECTRUM_000263
    NCGC00024646-03
    NINDS_000357
    479-03-8
    METHERGIN
    PARTERGIN
    METHYLERGONOVIN
    BPBIO1_000581
    BIOMOL-NT_000154
    METHYLERGOMETRINUM [INN-LATIN]
    IDI1_000357
    78207-86-0
    D-LYSERGIC ACID-(+)-BUTANOLAMIDE-(2)
    METHYLERGOMETRINE (INN)
    9,10-DIDEHYDRO-N-(1-(HYDROXYMETHYL)PROPYL)-6-METHYLERGOLINE-8-CARBOXAMIDE
    8226
    SPECTRUM3_000502
    DAP000978
    29477-86-9
    METHYLERGOBREVIN
    METHYLERGOMETRIN
    C20H25N3O2
    BPBIO1_000442
    SPECTRUM5_001879
    NCGC00024646-02
    SPECTRUM2_000613
    BASOFORTINA
    BRD-K34685430-001-01-1
    METHYLERGOMETRINUM
    KBIO2_000743
    D-LYSERGIC ACID-DL-HYDROXYBUTYLAMIDE-2
    AC1L1QJP
    N-(ALPHA-(HYDROXYMETHYL)PROPYL)-D-LYSERGAMIDE
    DB00353
    KBIO2_003311
    LYSERGAMIDE, N-((S)-1-(HYDROXYMETHYL)PROPYL)-
    METHERGINE
    DIVK1C_000357
    SPBIO_000546
    METILERGOMETRINIO
    KBIOSS_000743
    ME 277
    ERGOTYL
    SPAMETRIN-M
    CID8226
    EINECS 204-027-0
    METHERGEN
    (8BETA)-N-[(1S)-1-(HYDROXYMETHYL)PROPYL]-6-METHYL-9,10-DIDEHYDROERGOLINE-8-CARBOXAMIDE
    KBIO3_001523
    METENARIN
    METHYLERGOBASINE
    D08207
    METILERGOMETRINA
    BRD-K34685430-050-04-2
    (6AR,9R)-N-[(2S)-1-HYDROXYBUTAN-2-YL]-7-METHYL-6,6A,8,9-TETRAHYDRO-4H-INDOLO[4,3-FG]QUINOLINE-9-CARBOXAMIDE
    (4R,7R)-N-[(2S)-1-HYDROXYBUTAN-2-YL]-6-METHYL-6,11-DIAZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(16),2,9,12,14-PENTAENE-4-CARBOXAMIDE
    9,10-DIDEHYDRO-N-[1-(HYDROXYMETHYL)-PROPYL]-D-LYSERGAMIDE
    191038-EP2280008A2
    191038-EP2275420A1
    PL001019
    NCGC00017258-08
    NCGC00017258-06
    NCGC00017258-03
    CCG-204878
    TOX21_110809_1
    ZINC95619105
    BDBM50330860
    TOX21_110809
    W53L6FE61V
    D-LYSERGIC ACID 1-BUTANOLAMIDE
    GTPL150
    SCHEMBL78176
    CAS-113-42-8
    PARTAN M
    INGAGEN-M
    NEO-ERGO
    UTESEL
    MERGOT
    UTEROWIN
    UTERJIN
    UTERINE
    UTERGIN
    USAMEMA
    SATERGIN
    POSPARGIN
    MYOMETRIL
    MYOMERGIN
    METVELL
    METRINE
    METILER
    METILAT
    METHOVIN
    METERMIN
    MERGOTREX
    GLOMETHYL
    EXPOGIN
    ERGOMIN
    ERGOMED
    ERGOGIN
    DEMERGIN
    BLEDSTOP
    METHERSPAN
    METHERINAL
    DSSTOX_GSID_23283
    DSSTOX_RID_76957
    DSSTOX_CID_3283
    NCGC00017258-04
    135650591
    150

    Drug Info:

    FDA Approval 1946
    Drug Class small molecule
    Drug Indications Abortifacient Agents
    Drug Class abortifacient agents
    Year of Approval 1946
    (1 More Sources)

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Trial Name -
    Novel drug target Established target

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Specific Action of the Ligand Antagonist
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Specific Action of the Ligand Antagonist
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    agonist

    Interaction Info:
    Specific Action of the Ligand Full agonist
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    agonist

    Interaction Info:
    Specific Action of the Ligand Partial agonist
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    agonist

    Interaction Info:
    Specific Action of the Ligand Full agonist
    Endogenous Drug? False

    Publications:

    • Version: 01-August-2011

    Alternate Names:
    METHYLERGONOVINE Primary Drug Name

    Drug Info:
    Year of Approval 1946
    Drug Class abortifacient agents

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications Abortifacient Agents
    Drug Class small molecule
    FDA Approval 1946

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    BRD-K34685430-050-04-2 Drug Synonym
    METILERGOMETRINA Drug Synonym
    D08207 Drug Synonym

    Drug Info:

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    METHYLERGONOVINE pubchem_primary_name
    8226 PubChem CID
    METHYLERGOMETRINE Drug Synonym

    Drug Info:

    Publications:

    • Version: 27-September-2017

    Alternate Names:
    METHYLERGONOVINE GuideToPharmacology Ligand Name
    135650591 PubChem Drug SID

    Drug Info:

    Publications: